An in-vitro diagnostic is a process where diagnostic tests performed using analytical instruments and reagents on specific samples such as blood, urine, and other body fluids. The samples are gathered from patients or healthy individuals to identify and detect the diseases. The market is valued at USD XX billion in 2017 and is projected to USD XX billion by 2024 at a CAGR of 5.8%.
Mexico In-Vitro Diagnostics Market Share:
IVD plays a vital role in early diagnostics and detection of diseases. The point of care testing segment is holding the most significant share in the market at present.
Mexico In-Vitro Diagnostics Market Size:
North America is the leading one, and Mexico is expected to grow and dominate in forecast due to increasing acceptance of personalised medicine and growing adoption of advanced products and increase in chronic diseases patient pool and technological advancements. Asia-Pacific is expected to have highest CAGR during forecast due to growth in research and increasing investments.
Mexico In-Vitro Diagnostics Market Growth:
The market inclines due to the growth of healthcare expenditure in the emerging
Mexico In-Vitro Diagnostics Industry Analysis:
Application, product divide the market, and service, end user and technology. By application, it is categorised into diabetes, cancer, cardiology, autoimmune disease, drug testing, infectious disease, and nephrology. By the end-user market is segmented into hospitals, laboratories, point care testing, patient-care testing and academic industries. By technology, the market is into the immune disease, clinical chemistry, molecular diagnostics, Clinical microbiology, haematology, coagulation, and hemostasis by product the market is categorised into reagents and kits, instruments, consumables and data management services. By reusability, the market is segmented into reusable IVD devices and disposable IVD devices.
Mexico In-Vitro Diagnostics Market Outlook:
In-vitro means study of microorganisms, cells, biological molecules outside their biological context called test tube experiments. These diagnostics use analytical instruments and reagents on specific samples. North America is the leading one in the In-vitro diagnostics market.
Mexico In-Vitro Diagnostics Market Trends:
Danaher signed to acquire Cepheid for $ 4 billion and acquired Phenomenex for $ 700 million to expand in life sciences space. Siemens signed to acquire Mentor Graphics Corporation. Abbott announced that it had completed the acquisition of St. Jude Medical, Inc., the company as a leader in medical device arena.
Mexico In-Vitro Diagnostics Market Research Reports Include:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.